Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2019 4
2020 8
2021 7
2022 8
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.
Bramante CT, Buse JB, Liebovitz DM, Nicklas JM, Puskarich MA, Cohen K, Belani HK, Anderson BJ, Huling JD, Tignanelli CJ, Thompson JL, Pullen M, Wirtz EL, Siegel LK, Proper JL, Odde DJ, Klatt NR, Sherwood NE, Lindberg SM, Karger AB, Beckman KB, Erickson SM, Fenno SL, Hartman KM, Rose MR, Mehta T, Patel B, Griffiths G, Bhat NS, Murray TA, Boulware DR; COVID-OUT Study Team. Bramante CT, et al. Lancet Infect Dis. 2023 Oct;23(10):1119-1129. doi: 10.1016/S1473-3099(23)00299-2. Epub 2023 Jun 8. Lancet Infect Dis. 2023. PMID: 37302406 Clinical Trial.
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Proper JL, Siegel LK, Klatt NR, Odde DJ, Luke DG, Anderson B, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Biros M, Sherwood NE, Thompson JL, Boulware DR, Murray TA; COVID-OUT Trial Team. Bramante CT, et al. N Engl J Med. 2022 Aug 18;387(7):599-610. doi: 10.1056/NEJMoa2201662. N Engl J Med. 2022. PMID: 36070710 Free PMC article. Clinical Trial.
Financial inclusion for people with disability: a scoping review.
Puli L, Layton N, Bell D, Shahriar AZ. Puli L, et al. Among authors: shahriar az. Glob Health Action. 2024 Dec 31;17(1):2342634. doi: 10.1080/16549716.2024.2342634. Epub 2024 May 10. Glob Health Action. 2024. PMID: 38726584 Free PMC article. Review.
On One-Liners and Doing No Harm.
Shahriar AA. Shahriar AA. Acad Med. 2023 Oct 1;98(10):1184. doi: 10.1097/ACM.0000000000005324. Epub 2023 Jul 11. Acad Med. 2023. PMID: 37433209 No abstract available.
The Wrong Fight-Prior Authorization.
Shahriar AA. Shahriar AA. JAMA Oncol. 2024 Mar 1;10(3):295-296. doi: 10.1001/jamaoncol.2023.5801. JAMA Oncol. 2024. PMID: 38175626
The dual role of mir-146a in metastasis and disease progression.
Shahriar A, Ghaleh-Aziz Shiva G, Ghader B, Farhad J, Hosein A, Parsa H. Shahriar A, et al. Biomed Pharmacother. 2020 Jun;126:110099. doi: 10.1016/j.biopha.2020.110099. Epub 2020 Mar 13. Biomed Pharmacother. 2020. PMID: 32179200 Free article. Review.
A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation.
Rakib A, Nain Z, Sami SA, Mahmud S, Islam A, Ahmed S, Siddiqui ABF, Babu SMOF, Hossain P, Shahriar A, Nainu F, Emran TB, Simal-Gandara J. Rakib A, et al. Among authors: shahriar a. Brief Bioinform. 2021 Mar 22;22(2):1476-1498. doi: 10.1093/bib/bbab045. Brief Bioinform. 2021. PMID: 33623995 Free PMC article.
Water pollution in Bangladesh and its impact on public health.
Hasan MK, Shahriar A, Jim KU. Hasan MK, et al. Among authors: shahriar a. Heliyon. 2019 Aug 2;5(8):e02145. doi: 10.1016/j.heliyon.2019.e02145. eCollection 2019 Aug. Heliyon. 2019. PMID: 31406938 Free PMC article. Review.
Role of T cells in cancer immunotherapy: Opportunities and challenges.
Ahmed H, Mahmud AR, Siddiquee MF, Shahriar A, Biswas P, Shimul MEK, Ahmed SZ, Ema TI, Rahman N, Khan MA, Mizan MFR, Emran TB. Ahmed H, et al. Among authors: shahriar a. Cancer Pathog Ther. 2022 Dec 20;1(2):116-126. doi: 10.1016/j.cpt.2022.12.002. eCollection 2023 Apr. Cancer Pathog Ther. 2022. PMID: 38328405 Free PMC article. Review.
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches.
Emran TB, Shahriar A, Mahmud AR, Rahman T, Abir MH, Siddiquee MF, Ahmed H, Rahman N, Nainu F, Wahyudin E, Mitra S, Dhama K, Habiballah MM, Haque S, Islam A, Hassan MM. Emran TB, et al. Among authors: shahriar a. Front Oncol. 2022 Jun 23;12:891652. doi: 10.3389/fonc.2022.891652. eCollection 2022. Front Oncol. 2022. PMID: 35814435 Free PMC article. Review.
37 results